Here, our results show that cinobufagin has an anti-cancer effect by inhibiting LEF1-mediated activation of Wnt/β-catenin signaling, especially in LEF1 high expressing melanoma cells, indicating that cinobufagin is a promising natural pharmaceutical agent for melanoma treatment. This evidence concerns the gene LEF1 and cancer.